Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TENECTEPLASE Cause Haemorrhage intracranial? 74 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Haemorrhage intracranial have been filed in association with TENECTEPLASE (TNKase). This represents 5.6% of all adverse event reports for TENECTEPLASE.

74
Reports of Haemorrhage intracranial with TENECTEPLASE
5.6%
of all TENECTEPLASE reports
30
Deaths
19
Hospitalizations

How Dangerous Is Haemorrhage intracranial From TENECTEPLASE?

Of the 74 reports, 30 (40.5%) resulted in death, 19 (25.7%) required hospitalization, and 15 (20.3%) were considered life-threatening.

Is Haemorrhage intracranial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TENECTEPLASE. However, 74 reports have been filed with the FAERS database.

What Other Side Effects Does TENECTEPLASE Cause?

Off label use (430) No adverse event (313) Cerebral haemorrhage (132) Angioedema (112) Haemorrhage (71) Drug ineffective (68) Death (60) Haemorrhagic transformation stroke (49) Cerebrovascular accident (45) Subarachnoid haemorrhage (42)

What Other Drugs Cause Haemorrhage intracranial?

RIVAROXABAN (1,646) APIXABAN (1,244) ASPIRIN (1,103) WARFARIN (930) DABIGATRAN ETEXILATE (700) ALTEPLASE (615) CLOPIDOGREL BISULFATE (518) HEPARIN (302) CYCLOPHOSPHAMIDE (224) RITUXIMAB (210)

Which TENECTEPLASE Alternatives Have Lower Haemorrhage intracranial Risk?

TENECTEPLASE vs TENELIGLIPTIN TENECTEPLASE vs TENIPOSIDE TENECTEPLASE vs TENOFOVIR TENECTEPLASE vs TENOFOVIR ALAFENAMIDE TENECTEPLASE vs TENOFOVIR DISOPROXIL

Related Pages

TENECTEPLASE Full Profile All Haemorrhage intracranial Reports All Drugs Causing Haemorrhage intracranial TENECTEPLASE Demographics